Novo Nordisk
NVO
$122.75
Share price
-1.43%
Change (1 day)
44.60%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (NVO) - Total assets
Total assets on the balance sheet as of December 2023 : $46.57 B
According to Novo Nordisk's latest financial reports the company's total assets are $46.57 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Novo Nordisk - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $46.57 B | 34.06% |
| 2022-12-31 | $34.74 B | 17.32% |
| 2021-12-31 | $29.61 B | 23.62% |
| 2020-12-31 | $23.95 B | 27.2% |
| 2019-12-31 | $18.83 B | 10.97% |
| 2018-12-31 | $16.97 B | 2.85% |
| 2017-12-31 | $16.50 B | 19.48% |
| 2016-12-31 | $13.81 B | 2.66% |
| 2015-12-31 | $13.45 B | 6.88% |
| 2014-12-31 | $12.58 B | -3.35% |
| 2013-12-31 | $13.02 B | 11.84% |
| 2012-12-31 | $11.64 B | 3.31% |
| 2011-12-31 | $11.27 B | 2.85% |
| 2010-12-31 | $10.95 B | 3.91% |
| 2009-12-31 | $10.54 B | 10.71% |
| 2008-12-31 | $9.52 B | 1.84% |
| 2007-12-31 | $9.35 B | 18.02% |
| 2006-12-31 | $7.92 B | 19.47% |
| 2005-12-31 | $6.63 B | -3.33% |
| 2004-12-31 | $6.86 B | 17.64% |
| 2003-12-31 | $5.83 B | 29.82% |
| 2002-12-31 | $4.49 B | 9.1% |
| 2001-12-31 | $4.11 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 386.30% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 37.42% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 200.19% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $95.15 B | 104.31% | 🇺🇸 USA |